1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le dimanche 11 août 2019
Doi : 10.1016/j.jaad.2019.07.064
Optimizing presentation of expected treatment outcomes

Jeremy K. Bray, BA a, Matthew C. Johnson, BS a, E.J. Masicampo, PhD b, Steven R. Feldman, MD, PhD a, c, d,
a Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina 
b Department of Psychology, Wake Forest University, Winston-Salem, North Carolina 
c Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 
d Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina 

Reprint requests: Steven R. Feldman, MD, PhD, Wake Forest School of Medicine, Department of Dermatology, Medical Center Blvd, Winston-Salem, NC 27157-1071Wake Forest School of MedicineDepartment of DermatologyMedical Center BlvdWinston-SalemNC27157-1071

 Funding sources: None.
 Conflicts of interest: Dr Feldman has received research, speaking, consulting support, or a combination of these, from a variety of companies, including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Baxter, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Taro, AbbVie, Cosmederm, Anacor, Astellas, Janssen, Lilly, Merck, Merz, Novartis, Regeneron, Sanofi, Novan, Parion, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and the National Psoriasis Foundation. He is founder and majority owner of and founder and part owner of Causa Research, a company dedicated to enhancing patients' adherence to treatment. Authors Bray, Johnson, and Masicampo have no conflicts of interest to declare.

Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline